JP2009526084A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526084A5
JP2009526084A5 JP2008554516A JP2008554516A JP2009526084A5 JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5 JP 2008554516 A JP2008554516 A JP 2008554516A JP 2008554516 A JP2008554516 A JP 2008554516A JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5
Authority
JP
Japan
Prior art keywords
disease
pharmaceutical composition
composition according
inflammatory
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061909 external-priority patent/WO2008039553A1/en
Publication of JP2009526084A publication Critical patent/JP2009526084A/ja
Publication of JP2009526084A5 publication Critical patent/JP2009526084A5/ja
Pending legal-status Critical Current

Links

JP2008554516A 2006-02-10 2007-02-09 可溶性IL−17RCx4および炎症における使用法 Pending JP2009526084A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77217706P 2006-02-10 2006-02-10
US78107806P 2006-03-10 2006-03-10
PCT/US2007/061909 WO2008039553A1 (en) 2006-02-10 2007-02-09 Soluble il-17rcx4 and methods of using in inflammation

Publications (2)

Publication Number Publication Date
JP2009526084A JP2009526084A (ja) 2009-07-16
JP2009526084A5 true JP2009526084A5 (https=) 2010-03-18

Family

ID=38895865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554516A Pending JP2009526084A (ja) 2006-02-10 2007-02-09 可溶性IL−17RCx4および炎症における使用法

Country Status (10)

Country Link
US (2) US7622116B2 (https=)
EP (1) EP1987058B1 (https=)
JP (1) JP2009526084A (https=)
AT (1) ATE467640T1 (https=)
AU (1) AU2007300393B2 (https=)
CA (1) CA2638819A1 (https=)
DE (1) DE602007006429D1 (https=)
ES (1) ES2347840T3 (https=)
IL (1) IL192950A0 (https=)
WO (1) WO2008039553A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910540B2 (en) * 2004-06-10 2011-03-22 Zymogenetics, Inc. Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation
US7790676B2 (en) 2007-03-28 2010-09-07 Zymogenetics, Inc. Soluble IL-17RA/RC fusion proteins
US20100239590A1 (en) * 2007-06-20 2010-09-23 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
GB2464183A (en) * 2008-09-19 2010-04-14 Singulex Inc Sandwich assay
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
TWI541021B (zh) * 2009-03-05 2016-07-11 艾伯維有限公司 Il-17結合蛋白
WO2010144358A1 (en) 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels
JP2011032170A (ja) * 2009-07-29 2011-02-17 Morinaga Milk Ind Co Ltd ヒト細胞il−17産生抑制剤
US20130011413A1 (en) * 2010-02-03 2013-01-10 The University Of Tokyo Method and Pharmaceutical Composition for Treatment of Intestinal Disease
AU2011249908A1 (en) 2010-05-06 2012-11-22 Singulex, Inc. Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
WO2012097333A2 (en) 2011-01-14 2012-07-19 Redwood Bioscience, Inc. Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17
CN116059350A (zh) 2015-10-27 2023-05-05 Ucb生物制药有限责任公司 使用抗-il-17a/f抗体的治疗方法
JP2019515677A (ja) 2016-04-26 2019-06-13 アール.ピー.シェーラー テクノロジーズ エルエルシー 抗体複合体ならびにそれを作製および使用する方法
CN114107385A (zh) * 2019-01-17 2022-03-01 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.
CN112250764B (zh) * 2020-10-22 2022-07-29 深圳市康瑞克生物科技有限责任公司 一种抗白细胞介素17a的单克隆抗体、其编码基因及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684032A (en) 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
NZ306653A (en) 1995-03-23 1999-03-29 Immunex Corp Isolated dna il-17 receptors
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US20020177188A1 (en) 1998-05-15 2002-11-28 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
WO1998049307A1 (en) 1997-05-01 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like receptor
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
ES2333385T3 (es) 1997-09-17 2010-02-19 Human Genome Sciences, Inc. Proteina del tipo de interleuquina-17.
EP1078046A4 (en) 1998-05-12 2005-05-11 Human Genome Sciences Inc 97 HUMAN SECRETED PROTEINS
EP2241623A3 (en) 1999-07-07 2010-12-01 ZymoGenetics, Inc. Monoclonal antibody against a human cytokine receptor
US20030199041A1 (en) 1999-07-07 2003-10-23 Presnell Scott R. Interleukin-17 receptor homologue
ES2380812T3 (es) 1999-12-23 2012-05-18 Genentech, Inc. Polipéptidos homólogos a IL-17 y usos terapéuticos de los mismos
US20030092881A1 (en) 2000-05-24 2003-05-15 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
AU2001260847A1 (en) 2000-05-24 2001-12-03 Genesis Research And Development Corporation Limited Compositions isolated from skin cells and methods for their use
CA2425506A1 (en) * 2000-10-18 2002-08-01 Immunex Corporation Methods for treating rheumatoid arthritis using il-17 antagonists
WO2002038764A2 (en) 2000-11-10 2002-05-16 The Regents Of The University Of California Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
US20040097447A1 (en) 2002-11-16 2004-05-20 Isis Pharmaceuticals Inc. Modulation of interleukin 22 receptor expression
US7910540B2 (en) 2004-06-10 2011-03-22 Zymogenetics, Inc. Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation
GT200600065A (es) 2005-02-14 2006-10-02 Anticuerpos para interleucina-17f y otros antagonistas de la señalizacion de il-17f y sus usos
JP2009510093A (ja) * 2005-09-28 2009-03-12 ザイモジェネティクス, インコーポレイテッド Il−17aおよびil−17fアンタゴニストならびにその使用方法
US20070249533A1 (en) * 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same

Similar Documents

Publication Publication Date Title
JP2009526084A5 (https=)
JP2008509227A5 (https=)
JP2009534297A5 (https=)
JP2009510093A5 (https=)
JP2020193195A5 (https=)
JP2010511056A5 (https=)
JP2011526792A5 (https=)
US9920098B2 (en) Protein ligand for affinity isolation matrix
CN114957472B (zh) 抗IL-4Rα的单域抗体以及应用和药物
JP5913202B2 (ja) 改善された特異性を有する新規免疫グロブリン結合タンパク質
FI3592384T3 (fi) Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään
RU2009124453A (ru) Гетеродимерные полипептиды il-17 a/f и возможности их лечебного применения
JP2021507690A5 (https=)
CN104098694B (zh) 抗人β2微球蛋白的单域抗体及其制备方法和用途
HRP20140150T1 (hr) Antitijela koja vežu il-4 i/ili il-13 i njihova uporaba
JP2010500005A5 (https=)
JP2008508885A5 (https=)
RU2017118325A (ru) Слитые серпиновые полипептиды и способы их применения
JP2010220614A5 (https=)
RU2017145308A (ru) Слитые серпиновые полипептиды и способы их применения
JP2012519489A5 (https=)
JP2014530611A5 (https=)
JP2016510736A5 (https=)
JP2015524790A5 (https=)
JP2011520959A5 (https=)